Marc Cartellieri
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia.
Journal: Current opinion in hematology
Published: January 11, 2022
Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia.
Journal: Molecular therapy oncolytics
Published: March 28, 2020
TraFo-CRISPR: Enhanced Genome Engineering by Transient Foamy Virus Vector-Mediated Delivery of CRISPR/Cas9 Components.
Journal: Molecular therapy. Nucleic acids
Published: February 15, 2019
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells.
Journal: Cancer immunology, immunotherapy : CII
Published: September 01, 2018
Tonic Signaling and Its Effects on Lymphopoiesis of CAR-Armed Hematopoietic Stem and Progenitor Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 18, 2018
Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.
Journal: Journal of autoimmunity
Published: November 03, 2017
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells.
Journal: Oncotarget
Published: June 13, 2017
Last Updated: 09/26/2026